TDMS Study 05069-06 Pathology Tables
INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE
NTP Experiment-Test: 05069-06 Report: PEIRPT03
Study Type: INIT/PROMOT Date: 10/27/93
Route: DERMAL,SOLUTION Time: 13:18:19
Facility: TSI Mason Research
Chemical CAS #: 147-47-7
Lock Date: 09/17/93
Cage Range: All
Reasons For Removal: All
Removal Date Range: All
Treatment Groups: Include 009 DMBA/ ACETONE
Include 001 DMBA/TMQ5 MG/KG
Include 002 DMBA/TMQ10 MG/KG
Include 003 DMBA/TMQ25 MG/KG
Include 008 DMBA/TPA
a Number of animals examined microscopically at site and number of animals with lesion
Page 1
NTP Experiment-Test: 05069-06 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03
Study Type: INIT/PROMOT 1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE Date: 10/27/93
Route: DERMAL,SOLUTION Time: 13:18:19
____________________________________________________________________________________________________________________________________
SENCAR MICE FEMALE DMBA/ DMBA/TMQ DMBA/TMQ DMBA/TMQ DMBA/TPA
ACETONE 5 MG/KG 10 MG/KG 25 MG/KG
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY
Animals Initially In Study 30 30 30 30 30
Early Deaths
Moribund Sacrifice 2 1 2 1 18
Natural Death 1 1 2 3
Survivors
Terminal Sacrifice 26 28 28 26 9
Natural Death 1 1
Animals Examined Microscopically 30 30 30 30 30
____________________________________________________________________________________________________________________________________
ALIMENTARY SYSTEM
Gallbladder (1) (1)
Dilatation 1 (100%) 1 (100%)
Liver (30) (30) (30) (30) (30)
Congestion 1 (3%) 1 (3%) 1 (3%)
Fatty Change 1 (3%)
Hematopoietic Cell Proliferation 8 (27%) 5 (17%) 6 (20%) 5 (17%) 17 (57%)
Hepatodiaphragmatic Nodule 1 (3%)
Hyperplasia 1 (3%)
Inflammation 1 (3%)
Inflammation, Acute 1 (3%) 1 (3%)
Inflammation, Chronic 5 (17%) 4 (13%) 3 (10%) 3 (10%) 4 (13%)
Necrosis 3 (10%) 3 (10%) 4 (13%)
Pigmentation 2 (7%) 3 (10%) 4 (13%) 2 (7%) 1 (3%)
Centrilobular, Atrophy 1 (3%)
Kupffer Cell, Hyperplasia 1 (3%)
Portal, Fibrosis 1 (3%)
Mesentery (1)
Cyst 1 (100%)
____________________________________________________________________________________________________________________________________
CARDIOVASCULAR SYSTEM
None
____________________________________________________________________________________________________________________________________
ENDOCRINE SYSTEM
None
____________________________________________________________________________________________________________________________________
a Number of animals examined microscopically at site and number of animals with lesion
Page 2
NTP Experiment-Test: 05069-06 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03
Study Type: INIT/PROMOT 1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE Date: 10/27/93
Route: DERMAL,SOLUTION Time: 13:18:19
____________________________________________________________________________________________________________________________________
SENCAR MICE FEMALE DMBA/ DMBA/TMQ DMBA/TMQ DMBA/TMQ DMBA/TPA
ACETONE 5 MG/KG 10 MG/KG 25 MG/KG
____________________________________________________________________________________________________________________________________
GENERAL BODY SYSTEM
None
____________________________________________________________________________________________________________________________________
GENITAL SYSTEM
Ovary (2) (1) (1) (7)
Abscess 1 (50%)
Cyst 1 (50%) 1 (100%) 1 (100%) 6 (86%)
Cyst, Multiple 1 (14%)
Uterus (1) (5)
Hemorrhage 1 (100%)
Hyperplasia, Cystic 4 (80%)
____________________________________________________________________________________________________________________________________
HEMATOPOIETIC SYSTEM
Lymph Node (2) (1) (1) (1) (1)
Axillary, Hyperplasia, Lymphoid 1 (100%)
Axillary, Infiltration Cellular, 1 (100%)
Plasma Cell
Pancreatic, Cyst 1 (100%)
Pancreatic, Hyperplasia 1 (100%)
Spleen (2) (1) (1) (2) (7)
Hematopoietic Cell Proliferation 1 (50%) 1 (100%) 1 (50%) 7 (100%)
____________________________________________________________________________________________________________________________________
INTEGUMENTARY SYSTEM
Skin (30) (30) (30) (30) (30)
Back, Acanthosis 1 (3%) 1 (3%) 3 (10%) 29 (97%)
Back, Inflammation, Chronic 2 (7%) 10 (33%)
Back, Inflammation, Chronic Active 15 (50%)
Back, Ulcer 1 (3%) 7 (23%)
Back, Ulcer, Multiple 1 (3%)
Inguinal, Acanthosis 1 (3%) 1 (3%)
Inguinal, Inflammation, Chronic 1 (3%) 2 (7%)
Subcutaneous Tissue, Edema 1 (3%)
____________________________________________________________________________________________________________________________________
MUSCULOSKELETAL SYSTEM
None
____________________________________________________________________________________________________________________________________
a Number of animals examined microscopically at site and number of animals with lesion
Page 3
NTP Experiment-Test: 05069-06 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03
Study Type: INIT/PROMOT 1,2-DIHYDRO-2,2,4-TRIMETHYLQUINOLINE Date: 10/27/93
Route: DERMAL,SOLUTION Time: 13:18:19
____________________________________________________________________________________________________________________________________
SENCAR MICE FEMALE DMBA/ DMBA/TMQ DMBA/TMQ DMBA/TMQ DMBA/TPA
ACETONE 5 MG/KG 10 MG/KG 25 MG/KG
____________________________________________________________________________________________________________________________________
NERVOUS SYSTEM
None
____________________________________________________________________________________________________________________________________
RESPIRATORY SYSTEM
Lung (1) (1)
Infiltration Cellular, Lymphocyte 1 (100%)
____________________________________________________________________________________________________________________________________
SPECIAL SENSES SYSTEM
None
____________________________________________________________________________________________________________________________________
URINARY SYSTEM
Kidney (1)
Renal Tubule, Degeneration, Hyaline 1 (100%)
a Number of animals examined microscopically at site and number of animals with lesion
Page 4
------------------------------------------------------------
---------- END OF REPORT ----------
------------------------------------------------------------